Home
Zydus Lifesciences Ltd Board of Directors
Board of Directors at Zydus Lifesciences Ltd
Independent Director
Independent Director
Independent Director
Company Sec. & Compli. Officer
Whole-time Director
Key Highlights
- Pankaj R Patel continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
- Sharvil P Patel continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Mukesh M Patel joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Apurva S Diwanji joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ganesh N Nayak joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 885.1 |
20 Feb 2025 | 900.2 |
19 Feb 2025 | 891.4 |
18 Feb 2025 | 913.2 |
17 Feb 2025 | 924.15 |
14 Feb 2025 | 901.6 |
13 Feb 2025 | 942.45 |
12 Feb 2025 | 934.2 |
11 Feb 2025 | 941.65 |
10 Feb 2025 | 964.45 |
Company Fundamentals for Zydus Lifesciences Ltd
Market Cap
89,061 Cr
EPS
45.1
P/E Ratio (TTM)
19.6
P/B Ratio (TTM)
4.1
Day’s High
906.0
Day’s Low
882.35
DTE
0.0
ROE
19.7
52 Week High
1323.9
52 Week Low
862.2
ROCE
25.0
Market Price of Zydus Lifesciences Ltd
1M
1Y
3Y
5Y
Zydus Lifesciences Ltd News Hub
Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3
Read more
09 Aug 24
Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a
Read more
09 Aug 24
Zydus receives USFDA approval for Valbenazine Capsules
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (
Read more
09 Aug 24
Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.
Read more
08 Aug 24